RxDoctor Payments Data

Brian Shwer

Foot Surgery · Memphis, TNNPI 1588667414

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,602 of the $2,133 with a category attached, or 75.1%. 18 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 47.0% of the total. Reporting peaked in 2023 at $1,207 and has fallen 91.2% since, to $106 in 2025.

$2,133in general payments, 2019–2025

Across 65 payments — averaging $32.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$1K
  • Vaporox, Inc.$191
  • Zyla Life Sciences, Inc.$179
  • Smith+Nephew$132
  • Amgen$131
  • Stryker$109
  • plus $390 from 12 others

What the payments were for

  • Travel & lodging$53125%
  • Food & beverage$1,60275%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,133 in reported general payments places this provider in the 65th percentile of 23 foot surgery providers in Tennessee.

See all foot surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$195,961
Medicare patients
750
Services billed
2,327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox293$6,551
Diclofenac Sodium ErDiclofenac Sodium153$3,951
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort47$2,636
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip103$2,397
Mupirocin116$965
Diclofenac Sodium34$704
Methylprednisolone71$468
Pregabalin26$456
Doxycycline Hyclate48$449
Clindamycin Hcl49$429
Cephalexin115$418
Gabapentin81$394
Terbinafine Hcl14$257
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$226
Meloxicam17$75

Paid to pharmacies, not to this prescriber.

Other foot surgery in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →